MinnWest Technology Campus
MinnWest Technology Campus
MinnWest Starts Renovations for Epitopix, LLC

Work has started on another campus cottage. This renovation is for Epitopix, LLC.

Epitopix discovers and develops original veterinary vaccines to improve animal health and food safety. Epitopix vaccines are based on a novel process called SRP® Technology, discovered and patented by Epitopix microbiologists. These vaccines offer a revolutionary way to prevent bacterial diseases in livestock and poultry.

Epitopix will utilize this refurbished cottage for discovery, research, and development of new vaccines. This site will house approximately 12 scientists initially, but is expected to grow to thirty or more in the coming years. In addition, Epitopix is planning to build a new vaccine manufacturing plant near the R&D laboratory, which could employ an additional 100 employees or more.


View all news items

Current Campus
Employee Count:

[266]

Current Campus
Business Tenants:

[19]

Campus News:

Senior Vice President, Dr. Robert Jones comes to campus...
August 3, 2010 Dr. Robert Jones, Senior Vice President at the University of Minnesota, met ...

Pfizer Animal Health to Expand
6.11.2010  Pfizer Animal Health to Expand Access To E.Coli 0157 Vaccine From Epitopix For Beef ...

The Post-Bulletin Reports - “Biotech Backers Unite"
5.4.2010:  “Biotech Backers Unite to Promote local effort” – The ...

West Central Tribune Reports - "Gateway for Technology"
4.1.2010:  "MinnWest laboratory will be a ‘gateway’ for future technology ...

"This campus gave Nova-Tech the tools and atmosphere we needed to reach our potential."
-Jim Sieben, VP, General Manager, Nova-Tech Engineering, LLC